Bayer Aktiengesellschaft (BAYRY) Projected to Announce Earnings on Tuesday

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) is projected to issue its results before the market opens on Tuesday, November 3rd. Analysts expect Bayer Aktiengesellschaft to announce earnings of $0.13 per share and revenue of $11.25 billion for the quarter. Bayer Aktiengesellschaft has set its FY 2026 guidance at 1.200-1.346 EPS.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.29 earnings per share for the quarter, topping analysts’ consensus estimates of $0.23 by $0.06. Bayer Aktiengesellschaft had a positive return on equity of 16.77% and a negative net margin of 3.80%. The firm had revenue of $12.53 billion during the quarter, compared to analysts’ expectations of $12.31 billion. On average, analysts expect Bayer Aktiengesellschaft to post $1.27 EPS for the current fiscal year and $1.32 EPS for the next fiscal year.

Bayer Aktiengesellschaft Trading Up 3.2%

Shares of OTCMKTS:BAYRY opened at $12.69 on Tuesday. The business’s 50-day moving average is $13.52 and its 200 day moving average is $12.49. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.04 and a quick ratio of 0.67. Bayer Aktiengesellschaft has a 1 year low of $7.48 and a 1 year high of $15.23. The firm has a market capitalization of $49.87 billion, a P/E ratio of -24.88, a P/E/G ratio of 1.86 and a beta of 0.57.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the stock. Zacks Research upgraded shares of Bayer Aktiengesellschaft from a “hold” rating to a “strong-buy” rating in a report on Friday, July 10th. Deutsche Bank Aktiengesellschaft upgraded shares of Bayer Aktiengesellschaft from a “hold” rating to a “buy” rating in a research note on Thursday, July 2nd. Two investment analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Buy”.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft is a Germany-based life sciences company headquartered in Leverkusen. Founded in 1863 by Friedrich Bayer and Johann Friedrich Weskott, the company develops products in health care and agriculture and serves customers in markets around the world.

Bayer operates through three primary businesses: Pharmaceuticals, Consumer Health and Crop Science. Its Pharmaceuticals segment develops prescription medicines in areas such as cardiovascular disease, women’s health, oncology, hematology and specialty therapies.